| Author |
Title |
JournalName |
Year D |
| Click on Column Headers to Re-Sort The Current List |
| Maurer HH |
On the metabolism and the toxicological analysis of methylenedioxyphen... |
Ther Drug Monit |
1996 |
| Ensslin HK, Kovar KA, Mau... |
Toxicological detection of the designer drug 3,4-methylenedioxyethylam... |
J Chromatogr B Biome... |
1996 |
| Ensslin HK, Maurer HH, Go... |
Metabolism of racemic 3,4-methylenedioxyethylamphetamine in humans. Is... |
Drug Metab Dispos |
1997 |
| Maurer HH, Bickeboeller-F... |
Toxicokinetics and analytical toxicology of amphetamine-derived design... |
Toxicol Lett |
2000 |
| Kraemer T, Maurer HH |
Toxicokinetics of amphetamines: metabolism and toxicokinetic data of d... |
Ther Drug Monit |
2002 |
| Peters FT, Maurer HH, Hel... |
Prevalence of illicit drug use in plasmapheresis donors |
Vox Sang |
2003 |
| Peters FT, Schaefer S, St... |
Screening for and validated quantification of amphetamines and of amph... |
J Mass Spectrom |
2003 |
| Staack RF, Fritschi G, Ma... |
New designer drug 1-(3-trifluoromethylphenyl) piperazine (TFMPP): gas ... |
J Mass Spectrom |
2003 |
| Staack RF, Theobald DS, P... |
In vivo metabolism of the new designer drug 1-(4-methoxyphenyl)piperaz... |
Xenobiotica |
2004 |
| Maurer HH, Kraemer T, Spr... |
Chemistry, pharmacology, toxicology, and hepatic metabolism of designe... |
Ther Drug Monit |
2004 |
| Staack RF, Maurer HH |
Metabolism of designer drugs of abuse |
Curr Drug Metab |
2005 |
| Theobald DS, Staack RF, P... |
New designer drug 2,5-dimethoxy-4-ethylthio-beta-phenethylamine (2C-T-... |
J Mass Spectrom |
2005 |
| Ewald AH, Fritschi G, Bor... |
Designer drugs 2,5-dimethoxy-4-bromo-amphetamine DOB and 2,5-dimethoxy... |
J Mass Spectrom |
2006 |
| Ewald AH, Fritschi G, Mau... |
Designer drug 2,4,5-trimethoxyamphetamine (TMA-2): studies on its meta... |
J Mass Spectrom |
2006 |
| Ewald AH, Fritschi G, Mau... |
Designer drug 2,4,5-trimethoxyamphetamine TMA-2: studies on its metabo... |
J Mass Spectrom |
2006 |
| Theobald DS, Maurer HH |
Identification of monoamine oxidase and cytochrome P450 isoenzymes inv... |
Biochem Pharmacol |
2007 |
| Theobald DS, Fritschi G, ... |
Studies on the toxicological detection of the designer drug 4-bromo-2,... |
J Chromatogr B Analy... |
2007 |
| Mueller MA, Yuan J, Neudo... |
Further Studies on the Role of Metabolites in MDMA-induced Serotonergi... |
Drug Metab Dispos |
2009 |
| Meyer MR, Wilhelm J, Pete... |
Beta-keto amphetamines: studies on the metabolism of the designer drug... |
Anal Bioanal Chem |
2010 |
| Meyer MR, Maurer HH |
Metabolism of designer drugs of abuse: an updated review |
Curr Drug Metab |
2010 |
| Derungs A, Schietzel S, M... |
Sympathomimetic toxicity in a case of analytically confirmed recreatio... |
Clinical Toxicology |
2011 |
| Kapp FG, Maurer HH, Auwär... |
Intrahepatic cholestasis following abuse of powdered kratom (Mitragyna... |
J Med Toxicol |
2011 |
